Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease

The role of aspirin for primary prevention in older adults with chronic kidney disease (CKD) is unclear. Therefore, post hoc analysis of the randomized controlled trial ASPirin in Reducing Events in the Elderly (ASPREE) was undertaken comparing 100 mg of enteric-coated aspirin daily against matching...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int
Main Authors: Wolfe, Rory, Wetmore, James B., Woods, Robyn L., McNeil, John J., Gallagher, Hugh, Roderick, Paul, Walker, Rowan, Nelson, Mark R., Reid, Christopher M., Shah, Raj C., Ernst, Michael E., Lockery, Jessica E., Tonkin, Andrew M., Abhayaratna, Walter P., Gibbs, Peter, Wood, Erica M., Mahady, Suzanne E., Williamson, Jeff D., Donnan, Geoffrey A., Cloud, Geoffrey C., Murray, Anne M., Polkinghorne, Kevan R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957958/
https://ncbi.nlm.nih.gov/pubmed/32920022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2020.08.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados